Pfizer says it has begun studying the effects of a third dose of its COVID-19 vaccine, part of a strategy to combat new versions of the coronavirus.
Pfizer says it is planning to seek authorization from the Food and Drug Administration for a third dose of its COVID-19 vaccine as a booster shot.